Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013
Derivative liability	$ 775,199
Notes payable	773,279
Additional paid in capital	30,914,310
Accumulated deficit	(35,615,828)
Unaudited
Cash and cash equivalents	61,054
Due from related party	200,199
Promissory note	2,000
Total Current Assets	263,254
Patents	7,000
Total Assets	270,254
Accounts payable	797,908
Accrued expenses	2,094,508
Derivative liability	75,722
Notes payable	773,279
Notes payables	325,000
Convertible notes payable, net	32,504
Total Current Liabilities	4,098,921
Common stock (Par value $0.001 authorized 100,000,000 shares, issued and outstanding 96,554,322 and 93,209,823 at June 30, 2014 and December 31, 2013, respectively)	96,554
Additional paid in capital	32,220,773
Common stock-warrants	97,869
Deferred compensation
Accumulated deficit	(36,243,863)
Total stockholders deficit	(3,828,666)
Total Liabilities and stockholders deficit	270,254
Audited
Cash and cash equivalents		22,132
Due from related party		295,912
Promissory note		3,000
Total Current Assets		321,044
Patents		7,000
Total Assets		328,044
Accounts payable		797,908
Accrued expenses		1,986,726
Derivative liability		429,296
Notes payable		773,279
Notes payables		225,000
Convertible notes payable, net		117,534
Total Current Liabilities		4,329,743
Common stock (Par value $0.001 authorized 100,000,000 shares, issued and outstanding 96,554,322 and 93,209,823 at June 30, 2014 and December 31, 2013, respectively)		93,210
Additional paid in capital		30,078,730
Common stock-warrants		97,869
Deferred compensation		(12,609)
Accumulated deficit		(34,258,898)
Total stockholders deficit		(4,001,698)
Total Liabilities and stockholders deficit		$ 328,044